Position history for UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's holdings in UROGEN PHARMA LTD
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds 403 shares of URGN (UROGEN PHARMA LTD), worth $9,438 as of 2025-Q4. This is a new position.
Current Value
$9,438
Current Shares
403
Total Value Change
-$22.1M
Total Shares Change
-1.3M
Other major holders of URGN: MENORA MIVTACHIM HOLDINGS LTD., BNP PARIBAS FINANCIAL MARKETS, RTW INVESTMENTS, LP
New |
| 403 |
- |
| $9,438 |
| 0.0% |
| $23.17 |
26 |
| 2025-Q2 | Exited | 0 | -100.0% | $0 | 0.0% | $13.49 | 0 |
| 2025-Q1 | Increased | 4.4M | +216.6% | $48.2M | 0.0% | $11.20 | 47 |
| 2024-Q4 | Increased | 1.4M | +2.7% | $14.7M | 0.0% | $10.52 | 29 |
| 2024-Q3 | Increased | 1.3M | +1.6% | $17M | 0.0% | $12.90 | 29 |
| 2024-Q2 | New | 1.3M | - | $22.1M | 0.0% | $16.78 | 39 |